Vor Bio to Participate in Upcoming Investor Conferences
Vor Bio (Nasdaq: VOR) will participate in two upcoming investor conferences in November–December 2025. The company will host a fireside chat at the TD Cowen Virtual Immunology & Inflammation Summit on Wednesday, November 12, 2025 at 2:30 PM ET, and a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025 at 3:00 PM ET in Miami, FL.
A live webcast and archived replay of both fireside chats will be available on the investors section of www.vorbio.com.
Vor Bio (Nasdaq: VOR) parteciperà a due prossimi incontri con gli investitori nel periodo novembre-dicembre 2025. L'azienda ospiterà una chiacchierata informale al TD Cowen Virtual Immunology & Inflammation Summit mercoledì 12 novembre 2025 alle 14:30 ET, e una chiacchierata informale al 8th Annual Evercore Healthcare Conference martedì 2 dicembre 2025 alle 15:00 ET a Miami, FL.
Una trasmissione in diretta e la replay archiviata di entrambe le chiacchierate saranno disponibili nella sezione degli investitori di www.vorbio.com.
Vor Bio (Nasdaq: VOR) participará en dos próximas conferencias para inversores en noviembre-diciembre de 2025. La empresa llevará a cabo una charla informal durante el TD Cowen Virtual Immunology & Inflammation Summit el miércoles 12 de noviembre de 2025 a las 2:30 PM ET, y una charla informal durante la 8th Annual Evercore Healthcare Conference el martes 2 de diciembre de 2025 a las 3:00 PM ET en Miami, FL.
Habrá una transmisión en vivo y la repetición archivada de ambas charlas disponibles en la sección de inversores de www.vorbio.com.
Vor Bio (Nasdaq: VOR) 는 2025년 11월~12월에 예정된 두 차례의 투자자 행사에 참여합니다. 회사는 TD Cowen Virtual Immunology & Inflammation Summit에서 2025년 11월 12일 수요일 오후 2:30 ET에 fireside chat를 진행하고, 8th Annual Evercore Healthcare Conference에서 2025년 12월 2일 화요일 오후 3:00 ET에 마이애미, 플로리다에서 fireside chat를 개최합니다.
두 대화의 라이브 웹캐스트와 아카이브 재생은 투자자 섹션의 www.vorbio.com에서 이용 가능합니다.
Vor Bio (Nasdaq: VOR) participera à deux prochaines conférences d'investisseurs en novembre-décembre 2025. L'entreprise animera une discussion informelle lors du TD Cowen Virtual Immunology & Inflammation Summit le mercredi 12 novembre 2025 à 14h30 ET, et une discussion informelle lors de la 8th Annual Evercore Healthcare Conference le mardi 2 décembre 2025 à 15h00 ET à Miami, FL.
Une diffusion en direct et la rediffusion des deux discussions seront disponibles dans la section investisseurs de www.vorbio.com.
Vor Bio (Nasdaq: VOR) wird an zwei bevorstehenden Investorenkonferenzen im November–Dezember 2025 teilnehmen. Das Unternehmen wird einen Fireside-Chat beim TD Cowen Virtual Immunology & Inflammation Summit am Mittwoch, dem 12. November 2025 um 14:30 Uhr ET abhalten, und einen Fireside-Chat bei der 8th Annual Evercore Healthcare Conference am Dienstag, dem 2. Dezember 2025 um 15:00 Uhr ET in Miami, FL.
Eine Live-Übertragung und die archivierte Wiederholung beider Fireside Chats werden im Investorenbereich von www.vorbio.com verfügbar sein.
Vor Bio (Nasdaq: VOR) ستشارك في مؤتمرين للمستثمرين في نوفمبر-ديسمبر 2025. ستعقد الشركة محادثة على الموقد خلال قمة TD Cowen الافتراضية للمناعة والالتهاب الأربعاء 12 نوفمبر 2025 الساعة 2:30 مساءً بتوقيت شرق الولايات المتحدة، ومحادثة على الموقد خلال الاجتماع السنوي الثامن Evercore للرعاية الصحية يوم الثلاثاء 2 ديسمبر 2025 الساعة 3:00 مساءً بتوقيت شرق الولايات المتحدة في ميامي، فلوريدا.
ستكون هناك بث مباشر وتسجيل مكرر للمحادثتين على قسم المستثمرين في www.vorbio.com.
- None.
- None.
BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences:
TD Cowen Virtual Immunology & Inflammation Summit
Fireside Chat: Wednesday, November 12, 2025, at 2:30pm ET
8th Annual Evercore Healthcare Conference
Fireside Chat: Tuesday, December 2, 2025, 3:00pm ET
Location: Miami, FL
A live webcast and archived replay of the fireside chats will be available on the investors section of www.vorbio.com.
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.
Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com
Sarah Spencer
investors@vorbio.com
FAQ
When will Vor Bio (VOR) present at the TD Cowen Virtual Immunology & Inflammation Summit?
What time is Vor Bio (VOR) scheduled to speak at the Evercore Healthcare Conference?
Where can investors watch the Vor Bio (VOR) conference presentations live or on replay?
Will Vor Bio (VOR) present in person at the Evercore Healthcare Conference?
How can shareholders get notified about Vor Bio (VOR) conference webcasts and replays?
